Ana Martínez‐Feito

534 total citations
48 papers, 330 citations indexed

About

Ana Martínez‐Feito is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Ana Martínez‐Feito has authored 48 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 16 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Immunology. Recurrent topics in Ana Martínez‐Feito's work include Rheumatoid Arthritis Research and Therapies (29 papers), Systemic Lupus Erythematosus Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Ana Martínez‐Feito is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (29 papers), Systemic Lupus Erythematosus Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Ana Martínez‐Feito collaborates with scholars based in Spain, Netherlands and United States. Ana Martínez‐Feito's co-authors include Borja Hernández‐Breijo, Alejandro Balsa, Theo Rispens, Dora Pascual‐Salcedo, Karien Bloem, Chamaida Plasencia‐Rodríguez, Laura Nuño, Teresa Jurado‐Guerrero, Alejandro Villalba and Diana Peiteado and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Ana Martínez‐Feito

44 papers receiving 325 citations

Peers

Countries citing papers authored by Ana Martínez‐Feito

Since Specialization

Citations

This map shows the geographic impact of Ana Martínez‐Feito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martínez‐Feito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martínez‐Feito more than expected).

Fields of papers citing papers by Ana Martínez‐Feito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Martínez‐Feito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martínez‐Feito. The network helps show where Ana Martínez‐Feito may publish in the future.

Co-authorship network of co-authors of Ana Martínez‐Feito

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Martínez‐Feito. A scholar is included among the top collaborators of Ana Martínez‐Feito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Martínez‐Feito. Ana Martínez‐Feito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis? 2025 ·Nutrients ·Marta Novella-Navarro, Ana Maria Van Den Rym, C. López-Pedrera, Ana Martínez‐Feito, (unknown), (unknown), Clementina López‐Medina, Alejandro Escudero‐Contreras, Pilar Nozal, (unknown), I. Monjo, Eugenio de Miguel, Alejandro Balsa, Rebeca Pérez de Diego, Chamaida Plasencia‐Rodríguez	1
2	Epstein-Barr virus-specific T-cell response in pediatric liver transplant recipients: a cross-sectional study by multiparametric flow cytometry 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ana Martínez‐Feito, Eduardo López‐Granados, (unknown)	1
3	Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study 2024 ·RMD Open ·Clementina López‐Medina, J. Calvo-Gutiérrez, M. C. Ábalos‐Aguilera, (unknown), Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, Alejandro Balsa, (unknown), (unknown), Virginia Ruíz-Esquide, (unknown), Cèsar Díaz‐Torné, (unknown), (unknown), Natalia Mena‐Vázquez, Sara Manrique‐Arija, (unknown), R. Ortega Castro, Alejandro Escudero‐Contreras	8
4	Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases 2024 ·Lara D. Veeken ·Ana Martínez‐Feito, Marta Novella-Navarro, Borja Hernández‐Breijo, Pilar Nozal, Diana Peiteado, Alejandro Villalba, Laura Nuño, I. Monjo, Dora Pascual‐Salcedo, Alejandro Balsa, Chamaida Plasencia‐Rodríguez	4
5	Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients 2024 ·Frontiers in Medicine ·Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, Marta Novella-Navarro, Rebeca Pérez de Diego, Gema Bonilla, Johanna Elin Gehin, (unknown), Laura Nuño, Dora Pascual‐Salcedo, Pilar Nozal, (unknown), Alejandro Balsa	2
6	Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol 2023 ·BMJ Open ·(unknown), Irene García-García, Pedro Arias, Antonio J. Carcas, (unknown), Rosa Feltes, (unknown), Pedro Herranz, María Jiménez-González, Eduardo López Granados, Ana Martínez‐Feito, (unknown), (unknown), (unknown), Alberto M. Borobia	1
7	Detection of specific RBD+ IgG+ memory B cells by flow cytometry in healthcare workers and patients with inborn errors of immunity after BNT162b2 m RNA COVID-19 vaccination 2023 ·Frontiers in Immunology ·Lucía del Pino Molina, Luz Yadira Bravo‐Gallego, Pilar Nozal, (unknown), Ana Martínez‐Feito, (unknown), (unknown), (unknown), (unknown), Carmen Cámara, Juan González‐García, Miguel Á. Muñoz, Rebeca Rodríguez‐Pena, Eduardo López Granados	1
8	Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis 2022 ·Journal of Clinical Medicine ·Borja Hernández‐Breijo, Ioannis Parodis, Marta Novella-Navarro, Ana Martínez‐Feito, Victoria Navarro‐Compán, Mariana Díaz‐Almirón, Dora Pascual‐Salcedo, Alejandro Balsa, Chamaida Plasencia‐Rodríguez	5
9	BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors 2021 ·Scientific Reports ·Borja Hernández‐Breijo, Victoria Navarro‐Compán, Chamaida Plasencia‐Rodríguez, Ioannis Parodis, Johanna Elin Gehin, Ana Martínez‐Feito, Marta Novella-Navarro, (unknown), David J. Warren, Pilar Nozal, Dora Pascual‐Salcedo, Alejandro Balsa	6
10	Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis 2021 ·Frontiers in Medicine ·Borja Hernández‐Breijo, (unknown), Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, Marta Novella-Navarro, Dora Pascual‐Salcedo, Alejandro Balsa	6
11	Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies 2021 ·Scientific Reports ·(unknown), Laura Nuño, (unknown), Ana M. Ortiz, Alejandro Villalba, M. Dolores Bóveda, Ana Martínez‐Feito, Carmen Conde, Alejandro Balsa, Isidoro González‐Álvaro, Antonio González	4
12	Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis 2021 ·Frontiers in Medicine ·Borja Hernández‐Breijo, Chamaida Plasencia‐Rodríguez, Victoria Navarro‐Compán, Carlota García‐Hoz, (unknown), Cristina Sobrino, Javier Bachiller‐Corral, Mariana Díaz‐Almirón, Ana Martínez‐Feito, Teresa Jurado‐Guerrero, (unknown), Gema Bonilla, (unknown), Garbiñe Roy, Mónica Vázquez Díaz, Alejandro Balsa, Luisa María Villar, Dora Pascual‐Salcedo, Eulalia Rodrı́guez-Martı́n	2
13	Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies 2020 ·Scientific Reports ·(unknown), Holger Bang, (unknown), Laura Nuño, (unknown), Diana Peiteado, Ana M. Ortiz, Alejandro Villalba, Ana Martínez‐Feito, Alejandro Balsa, Isidoro González‐Álvaro, Antonio González	10
14	Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar 2020 ·Scientific Reports ·Ana Martínez‐Feito, Luz Yadira Bravo‐Gallego, Borja Hernández‐Breijo, Jesús Díez‐Manglano, (unknown), (unknown), Chamaida Plasencia‐Rodríguez, Pilar Nozal, (unknown), María Dolores Martin‐Arranz, Dora Pascual‐Salcedo	2
15	Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis 2020 ·Frontiers in Immunology ·Eulalia Rodrı́guez-Martı́n, (unknown), Borja Hernández‐Breijo, Cristina Sobrino, Carlota García‐Hoz, Javier Bachiller‐Corral, Ana Martínez‐Feito, Victoria Navarro‐Compán, (unknown), Gema Bonilla, Dora Pascual‐Salcedo, Garbiñe Roy, Teresa Jurado‐Guerrero, Pilar Nozal, Mónica Vázquez Díaz, Alejandro Balsa, Luisa María Villar, Chamaida Plasencia‐Rodríguez	5
16	Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis 2019 ·Arthritis Research & Therapy ·Borja Hernández‐Breijo, Chamaida Plasencia‐Rodríguez, Victoria Navarro‐Compán, Ana Martínez‐Feito, (unknown), E. Kneepkens, Gertjan Wolbink, Theo Rispens, (unknown), Dora Pascual‐Salcedo, Alejandro Balsa	11
17	FRI0186 Concomitant csdmards influence clinical response to tnf inhibitors only in overweight patients with axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·Borja Hernández‐Breijo, Victoria Navarro‐Compán, Ana Martínez‐Feito, (unknown), (unknown), Diana Peiteado, E. Kneepkens, Pilar Nozal, Gertjan Wolbink, Theo Rispens, Dora Pascual‐Salcedo, Alejandro Balsa, Chamaida Plasencia‐Rodríguez	1
18	The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors 2018 ·Clinical Rheumatology ·Ana Martínez‐Feito, Chamaida Plasencia‐Rodríguez, Victoria Navarro‐Compán, Borja Hernández‐Breijo, (unknown), I. Monjo, Laura Nuño, Pilar Nozal, Dora Pascual‐Salcedo, Alejandro Balsa	13
19	Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients 2017 ·Scientific Reports ·(unknown), Laura Nuño, Ana M. Ortiz, Diana Peiteado, Alejandro Villalba, Dora Pascual‐Salcedo, Ana Martínez‐Feito, Isidoro González‐Álvaro, Alejandro Balsa, Antonio González	18
20	Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation 2015 ·Immunobiology ·Ana Martínez‐Feito, (unknown), (unknown), (unknown), (unknown), Luis Ignacio González‐Granado, (unknown), (unknown), Raquel Ruiz‐García, (unknown), (unknown), Estela Paz‐Artal, (unknown), (unknown), Luis M. Allende	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact